Evidence map›Paper›PMID 35279671›Full record

ArticleScientific reports2022

Quality of life of children with neurodevelopmental disorders and their parents during the COVID-19 pandemic: a 1-year follow-up study.

Riyo Ueda, Takashi Okada, Yosuke Kita, Masatoshi Ukezono, Miki Takada, Yuri Ozawa, Hisami Inoue, Mutsuki Shioda, Yoshimi Kono, Chika Kono and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. COVID-19 Pandemic: 1-Year Follow-Up in Children and Adolescents with Neuropsychiatric Disorders.International journal of environmental research and public health · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Riyo UedaDepartment of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-Cho, Kodaira, Tokyo, 187-8553, Japan. uedariyo1166@gmail.com.
Takashi OkadaDepartment of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-Cho, Kodaira, Tokyo, 187-8553, Japan.
Yosuke KitaMori Arinori Center for Higher Education and Global Mobility, Hitotsubashi University, Tokyo, Japan.
Masatoshi UkezonoDepartment of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-Cho, Kodaira, Tokyo, 187-8553, Japan.
Miki TakadaDepartment of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-Cho, Kodaira, Tokyo, 187-8553, Japan.
Yuri OzawaDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Hisami InoueDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Mutsuki ShiodaDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Yoshimi KonoDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Chika KonoDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Yukiko NakamuraDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Kaoru AmemiyaDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Ai ItoDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Nobuko SugiuraDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Yuichiro MatsuokaDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Chinami KaigaDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Yasuko ShirakiDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Masaya KubotaDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Hiroshi OzawaDepartment of Child Neurology, Shimada Ryoiku Medical Center Hachioji for Challenged Children, Tokyo, Japan.
Tobu Ryoiku Center · JPNational Center of Neurology and Psychiatry · JPNational Institute of Mental Health · JPHitotsubashi University · JP

Funding

Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP 1-4Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP 2-7
6 · The paper itself

Abstract

This study aimed to reveal changes in the quality of life (QOL) of children with neurodevelopmental disorders and their parents, and the interaction between their QOL and parental mental state during the coronavirus 2019 (COVID-19) pandemic. Eighty-nine school-aged children and parents participated in surveys in May 2020 (T1) and May 2021 (T2). The parents completed questionnaires that assessed their QOL, depression, parenting stress, and living conditions. Children's temporary mood status was evaluated using the self-reported visual analog scale (VAS). Children's QOL and VAS at T2 were higher than their QOL at T1. Parents' QOL at T2 was lower than their QOL at T1. Severe parental depression at T1 had a synergistic effect on severe parenting stress and severe depressive state at T2. Additionally, children's high QOL at T1 had a synergistic effect on low parenting stress and children's high QOL at T2. Furthermore, children's low VAS scores and parents' low QOL at T2 were associated with deterioration of family economic status. Children and parents' QOL changed during the prolonged COVID-19 pandemic. Improvement in children's QOL was influenced by reduced maternal depressive symptoms. Public support for parental mental health is important to avoid decreasing QOL.

Indexed as

Quality of LifeAdultChildCOVID-19DepressionFemaleFollow-Up StudiesHumansMaleNeurodevelopmental DisordersParentsSocioeconomic FactorsStress, PsychologicalSurveys and Questionnaires

Identifiers

PMID35279671
PMCPMC8918332
OpenAlexW4220789507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.